SUSQUEHANNA INTERNATIONAL GROUP, LLP - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 45 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$984,000
-59.8%
1,576,692
-45.6%
0.00%
Q3 2019$2,446,000
-55.2%
2,896,245
-64.3%
0.00%
Q2 2019$5,458,000
+254.9%
8,106,612
+332.4%
0.00%
Q1 2019$1,538,000
-64.8%
1,875,000
-31.3%
0.00%
-100.0%
Q4 2018$4,367,000
-45.7%
2,729,581
+12.3%
0.00%
-66.7%
Q3 2018$8,045,000
+144.8%
2,430,600
+67.1%
0.00%
+200.0%
Q2 2018$3,287,000
-34.0%
1,454,600
-15.3%
0.00%
-50.0%
Q1 2018$4,979,000
+34.5%
1,717,305
+29.4%
0.00%
+100.0%
Q4 2017$3,703,000
+26.1%
1,326,892
+64.9%
0.00%0.0%
Q3 2017$2,936,000
+358.0%
804,500
+179.0%
0.00%
Q2 2017$641,000
+404.7%
288,400
+22.9%
0.00%
Q4 2016$127,000
+38.0%
234,698
+146.0%
0.00%
Q2 2016$92,000
+55.9%
95,403
+47.7%
0.00%
Q1 2016$59,000
+47.5%
64,597
+104.4%
0.00%
Q4 2015$40,000
-70.4%
31,607
-71.5%
0.00%
Q3 2015$135,000
-21.1%
111,018
+12.8%
0.00%
Q2 2015$171,000
-35.0%
98,426
-45.6%
0.00%
Q1 2015$263,000
+67.5%
180,795
-3.3%
0.00%
Q4 2014$157,000
-35.1%
187,013
-14.1%
0.00%
Q3 2014$242,000
+36.0%
217,659
+123.5%
0.00%
Q2 2014$178,000
+249.0%
97,405
+190.4%
0.00%
Q1 2014$51,000
+112.5%
33,536
+161.3%
0.00%
Q4 2013$24,000
-91.9%
12,832
-91.0%
0.00%
Q3 2013$295,000
-19.0%
142,402
-2.2%
0.00%
Q2 2013$364,000145,5660.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Greylock XI GP Limited Partnership 584,004$1,068,000100.00%
GREAT POINT PARTNERS LLC 2,325,000$4,255,0001.89%
Sarissa Capital Management LP 2,570,759$4,704,0001.60%
Deer VI & Co. LLC 675,242$1,236,0000.68%
Palo Alto Investors LP 1,200,800$2,197,0000.16%
Baupost Group 3,829,350$7,008,0000.11%
Gruss Capital Management LP 533,253$976,0000.05%
Granahan Investment Management 676,451$1,238,0000.04%
Fore Research & Management, LP 674,200$1,233,0000.04%
TFS CAPITAL LLC 210,369$385,0000.03%
View complete list of AVEO PHARMACEUTICALS INC shareholders